The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us
5139 Westlawn
Iowa City IA 52242
(319) 335-8032; fax(319) 335-8034

Release: Oct. 4, 2000

Sherman to receive award from UI department of internal medicine

IOWA CITY, Iowa -- Barry M. Sherman, M.D., a former faculty member in the University of Iowa department of internal medicine, will receive the department's Distinguished Achievement Award for his professional contributions in internal medicine.

Sherman will receive the award at 1 p.m. Thursday, Oct. 5 in the Medical Alumni Auditorium at the UI Hospitals and Clinics. The presentation is part of "Progress in Internal Medicine," an annual conference for medical professionals held on the UI campus. Francois M. Abboud, M.D., professor and head of the UI department of internal medicine, will present the award. Following the presentation, Sherman will give a lecture titled, "The Promise of New Drug Development."

Sherman served as associate director (1971-1977) and director (1977-1985) of the UI Clinical Research Center, overseeing the clinical research activities of UI faculty members from various departments. His own research at the UI made significant contributions in three major areas: human female reproductive endocrinology; pituitary function and pituitary tumors; and endocrine changes in patients with psychiatric illnesses. While at Iowa, Sherman also served as associate chair for academic programs in the UI department of internal medicine, and as chair of the UI College of Medicine's compensation committee. He played a major role in the college's efforts related to faculty compensation, promotion and recruitment.

In 1985, Sherman left the UI to become director of clinical research at Genetech, then a new San Francisco-based biotechnology company that became a model for the biotech industry. He eventually became senior vice president and chief medical officer at the company, overseeing an
11-year boom in new drug development that included human growth hormones, human insulin and cancer treatments.

Sherman is currently executive vice president and chief medical officer for Pain Therapeutics, a drug development firm whose goal is to create less addictive pain relievers.

University of Iowa Health Care describes the partnership between the UI College of Medicine and the UI Hospitals and Clinics and the patient care, medical education and research programs and services they provide.